T Beukelman

Summary

Affiliation: University of Alabama at Birmingham
Country: USA

Publications

  1. pmc Sarcoidosis in a young child with Alagille syndrome: a case report
    Melissa Mannion
    Department of Pediatrics, Division of Rheumatology, University of Alabama at Birmingham, Birmingham, AL, USA
    Pediatr Rheumatol Online J 10:32. 2012
  2. pmc Back mobility and interincisor distance ranges in racially diverse North American healthy children and relationship to generalized hypermobility
    Sophie L Woolston
    Department of Pediatrics, Rheumatology, The Children s Hospital of Philadelphia, 34th and Civic Center Blvd, Philadelphia, PA, 19104, USA
    Pediatr Rheumatol Online J 10:17. 2012
  3. pmc Retinal vasculitis in two pediatric patients with systemic lupus erythematosus: a case report
    Katherine J Donnithorne
    Department of Pediatrics, Division of Rheumatology, University of Alabama at Birmingham, Birmingham, AL, USA
    Pediatr Rheumatol Online J 11:25. 2013
  4. pmc Brief report: incidence of selected opportunistic infections among children with juvenile idiopathic arthritis
    Timothy Beukelman
    University of Alabama at Birmingham, Division of Pediatric Rheumatology, Birmingham, AL 35233 1711, USA
    Arthritis Rheum 65:1384-9. 2013
  5. pmc Disease-modifying antirheumatic drug use in the treatment of juvenile idiopathic arthritis: a cross-sectional analysis of the CARRA Registry
    Timothy Beukelman
    Division of Pediatric Rheumatology, University of Alabama at Birmingham, 1600 7th Ave South, CPP 210, Birmingham, AL 35233 1711, USA
    J Rheumatol 39:1867-74. 2012
  6. pmc Rates of hospitalized bacterial infection associated with juvenile idiopathic arthritis and its treatment
    Timothy Beukelman
    University of Alabama at Birmingham, Division of Pediatric Rheumatology, 1600 7th Avenue South, CPP 210, Birmingham, AL 35233 1711, USA
    Arthritis Rheum 64:2773-80. 2012
  7. pmc Rates of malignancy associated with juvenile idiopathic arthritis and its treatment
    Timothy Beukelman
    University of Alabama at Birmingham, Birmingham, AL 35233 1711, USA
    Arthritis Rheum 64:1263-71. 2012
  8. pmc High prevalence of myositis in a southeastern United States pediatric systemic lupus erythematosus cohort
    Jessica L Record
    Department of Pediatrics, Division of Rheumatology, University of Alabama at Birmingham, Birmingham, Alabama 35294, USA
    Pediatr Rheumatol Online J 9:20. 2011
  9. pmc Guilt by association - what is the true risk of malignancy in children treated with etanercept for JIA?
    Randy Q Cron
    Department of Pediatrics, Division of Rheumatology, University of Alabama at Birmingham, Birmingham, AL 35294, USA
    Pediatr Rheumatol Online J 8:23. 2010
  10. doi request reprint Cost-effectiveness of multifaceted evidence implementation programs for the prevention of glucocorticoid-induced osteoporosis
    T Beukelman
    University of Alabama at Birmingham, Deep South Musculoskeletal Center for Education and Research on Therapeutics, Birmingham, AL 35294 3408, USA
    Osteoporos Int 21:1573-84. 2010

Collaborators

Detail Information

Publications20

  1. pmc Sarcoidosis in a young child with Alagille syndrome: a case report
    Melissa Mannion
    Department of Pediatrics, Division of Rheumatology, University of Alabama at Birmingham, Birmingham, AL, USA
    Pediatr Rheumatol Online J 10:32. 2012
    ..We briefly review these two seemingly unrelated conditions and propose a possible common pathogenic mechanism...
  2. pmc Back mobility and interincisor distance ranges in racially diverse North American healthy children and relationship to generalized hypermobility
    Sophie L Woolston
    Department of Pediatrics, Rheumatology, The Children s Hospital of Philadelphia, 34th and Civic Center Blvd, Philadelphia, PA, 19104, USA
    Pediatr Rheumatol Online J 10:17. 2012
    ..abstract:..
  3. pmc Retinal vasculitis in two pediatric patients with systemic lupus erythematosus: a case report
    Katherine J Donnithorne
    Department of Pediatrics, Division of Rheumatology, University of Alabama at Birmingham, Birmingham, AL, USA
    Pediatr Rheumatol Online J 11:25. 2013
    ..We suggest that early recognition of disease and early intervention with B-cell depletion therapy in addition to a traditional cytotoxic agent should be considered in pediatric patients with SLE and occlusive retinopathy...
  4. pmc Brief report: incidence of selected opportunistic infections among children with juvenile idiopathic arthritis
    Timothy Beukelman
    University of Alabama at Birmingham, Division of Pediatric Rheumatology, Birmingham, AL 35233 1711, USA
    Arthritis Rheum 65:1384-9. 2013
    ..To compare incidence rates of selected opportunistic infections among children with and children without juvenile idiopathic arthritis (JIA)...
  5. pmc Disease-modifying antirheumatic drug use in the treatment of juvenile idiopathic arthritis: a cross-sectional analysis of the CARRA Registry
    Timothy Beukelman
    Division of Pediatric Rheumatology, University of Alabama at Birmingham, 1600 7th Ave South, CPP 210, Birmingham, AL 35233 1711, USA
    J Rheumatol 39:1867-74. 2012
    ..To characterize disease-modifying antirheumatic drug (DMARD) use for children with juvenile idiopathic arthritis (JIA) in the United States and to determine patient factors associated with medication use...
  6. pmc Rates of hospitalized bacterial infection associated with juvenile idiopathic arthritis and its treatment
    Timothy Beukelman
    University of Alabama at Birmingham, Division of Pediatric Rheumatology, 1600 7th Avenue South, CPP 210, Birmingham, AL 35233 1711, USA
    Arthritis Rheum 64:2773-80. 2012
    ..To compare the incidence of hospitalized bacterial infections among children with and children without juvenile idiopathic arthritis (JIA) and to examine the effects of selected medications...
  7. pmc Rates of malignancy associated with juvenile idiopathic arthritis and its treatment
    Timothy Beukelman
    University of Alabama at Birmingham, Birmingham, AL 35233 1711, USA
    Arthritis Rheum 64:1263-71. 2012
    ..To determine the relative rates of incident malignancy among children with juvenile idiopathic arthritis (JIA) with respect to treatment as compared to children without JIA...
  8. pmc High prevalence of myositis in a southeastern United States pediatric systemic lupus erythematosus cohort
    Jessica L Record
    Department of Pediatrics, Division of Rheumatology, University of Alabama at Birmingham, Birmingham, Alabama 35294, USA
    Pediatr Rheumatol Online J 9:20. 2011
    ....
  9. pmc Guilt by association - what is the true risk of malignancy in children treated with etanercept for JIA?
    Randy Q Cron
    Department of Pediatrics, Division of Rheumatology, University of Alabama at Birmingham, Birmingham, AL 35294, USA
    Pediatr Rheumatol Online J 8:23. 2010
    ....
  10. doi request reprint Cost-effectiveness of multifaceted evidence implementation programs for the prevention of glucocorticoid-induced osteoporosis
    T Beukelman
    University of Alabama at Birmingham, Deep South Musculoskeletal Center for Education and Research on Therapeutics, Birmingham, AL 35294 3408, USA
    Osteoporos Int 21:1573-84. 2010
    ....
  11. ncbi request reprint Usage of intra-articular corticosteroid injections for the treatment of juvenile idiopathic arthritis: a survey of pediatric rheumatologists in the United States and Canada
    T Beukelman
    Department of Pediatrics, Division of Rheumatology, University of Alabama at Birmingham, AL 35294, USA
    Clin Exp Rheumatol 26:700-3. 2008
    ..To characterize the current usage of intra-articular corticosteroid injections (IACI) by pediatric rheumatologists and the perceived disadvantages of and obstacles to IACI therapy...
  12. doi request reprint Optimal treatment of knee monarthritis in juvenile idiopathic arthritis: a decision analysis
    Timothy Beukelman
    The University of Alabama at Birmingham, Birmingham, AL 35294 3408, USA
    Arthritis Rheum 59:1580-8. 2008
    ..To identify the optimal initial treatment strategy for knee monarthritis in juvenile idiopathic arthritis (JIA) using a decision model and parents' preferences...
  13. pmc Attainment of inactive disease status following initiation of TNF-α inhibitor therapy for juvenile idiopathic arthritis: enthesitis-related arthritis predicts persistent active disease
    Katherine J Donnithorne
    University of Alabama School of Medicine, Birmingham, AL 35233, USA
    J Rheumatol 38:2675-81. 2011
    ..To analyze the attainment of inactive disease following initiation of tumor necrosis factor-α (TNF-α) inhibitors in a heterogeneous cohort of children with juvenile idiopathic arthritis (JIA)...
  14. pmc Elevated liver enzyme tests among patients with rheumatoid arthritis or psoriatic arthritis treated with methotrexate and/or leflunomide
    J R Curtis
    Division of Clinical Immunology and Rheumatology, University of Alabama at Birmingham, 510 20 Street South, FOT 840, Birmingham, AL 35294, USA
    Ann Rheum Dis 69:43-7. 2010
    ....
  15. ncbi request reprint Variation in the initial treatment of knee monoarthritis in juvenile idiopathic arthritis: a survey of pediatric rheumatologists in the United States and Canada
    Timothy Beukelman
    Department of Pediatrics, Division of Rheumatology and Division of General Pediatrics, The Children s Hospital of Philadelphia, Philadelphia, Pennsylvania, USA
    J Rheumatol 34:1918-24. 2007
    ....
  16. pmc Incidence and risk factors for progressive multifocal leukoencephalopathy among patients with selected rheumatic diseases
    A Bharat
    University of Alabama at Birmingham, AL, USA
    Arthritis Care Res (Hoboken) 64:612-5. 2012
    ....
  17. ncbi request reprint Benefit of intraarticular corticosteroid injection under fluoroscopic guidance for subtalar arthritis in juvenile idiopathic arthritis
    Timothy Beukelman
    Department of Pediatrics, Division of Rheumatology, Children s Hospital of Philadelphia, 3615 Civic Center Boulevard, Philadelphia, PA 19104, USA
    J Rheumatol 33:2330-6. 2006
    ..To determine the demographics of subtalar arthritis, the response to intraarticular corticosteroid injection, and the injection complication rate in a clinic sample of children with juvenile idiopathic arthritis (JIA)...
  18. doi request reprint Rituximab therapy for severe refractory chronic Henoch-Schönlein purpura
    Katherine J Donnithorne
    University of Alabama at Birmingham School of Medicine, Birmingham, AL, USA
    J Pediatr 155:136-9. 2009
    ..All 3 patients responded to 1 or 2 courses of RTX without serious adverse events...
  19. ncbi request reprint Evaluation of the presentation of systemic onset juvenile rheumatoid arthritis: data from the Pennsylvania Systemic Onset Juvenile Arthritis Registry (PASOJAR)
    Edward M Behrens
    Department of Pediatrics, Division of Rheumatology, The Children s Hospital of Philadelphia, Philadelphia, Pennsylvania 19104 4318, USA
    J Rheumatol 35:343-8. 2008
    ..To characterize the initial clinical and laboratory features of patients with systemic onset juvenile rheumatoid arthritis (soJRA) through a Web-based registry...
  20. ncbi request reprint Occult macrophage activation syndrome in patients with systemic juvenile idiopathic arthritis
    Edward M Behrens
    Departments of Pathology and Pediatrics, Division of Rheumatology, Children s Hospital of Philadelphia, and University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania 19104 4318, USA
    J Rheumatol 34:1133-8. 2007
    ..Accordingly, many patients with SJIA may have evidence of mild MAS that is not appreciated clinically. We investigated the prevalence of occult MAS in children with SJIA by reviewing bone marrow aspirates (BMA)...